Orphapacket:
  AverageAgeOfDeaths:
  - AverageAgeOfDeath:
      value: no data
  - AverageAgeOfDeath:
      value: no data
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '608266'
    Source: OMIM
  Genes:
  - Gene:
      ExternalReferences: []
      Name: cell division cycle 73
      Symbol: CDC73
  Label: Parathyroid carcinoma
  ORPHAcode: '143'
  ORPHApacketId: '143'
  PURL: http://www.orpha.net/ORDO/Orphanet_143
  Parents:
  - Parent:
    - Label: Rare parathyroid tumor
      ORPHAcode: '100090'
  - Parent:
    - Label: Rare hyperparathyroidism
      ORPHAcode: '181408'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Obligate (100%)
      HPOId: HP:0003072
      HPOTerm: Hypercalcemia
  - Phenotype:
      HPOFrequency: Obligate (100%)
      HPOId: HP:0006780
      HPOTerm: Parathyroid carcinoma
  - Phenotype:
      HPOFrequency: Obligate (100%)
      HPOId: HP:0008200
      HPOTerm: Primary hyperparathyroidism
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002148
      HPOTerm: Hypophosphatemia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002150
      HPOTerm: Hypercalciuria
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003165
      HPOTerm: Elevated circulating parathyroid hormone level
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0011766
      HPOTerm: Abnormality of the parathyroid morphology
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000121
      HPOTerm: Nephrocalcinosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000131
      HPOTerm: Uterine leiomyoma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000787
      HPOTerm: Nephrolithiasis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000939
      HPOTerm: Osteoporosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001609
      HPOTerm: Hoarse voice
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001959
      HPOTerm: Polydipsia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002015
      HPOTerm: Dysphagia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0008250
      HPOTerm: Infantile hypercalcemia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0010614
      HPOTerm: Fibroma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012232
      HPOTerm: Shortened QT interval
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000083
      HPOTerm: Renal insufficiency
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000107
      HPOTerm: Renal cyst
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000934
      HPOTerm: Chondrocalcinosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001324
      HPOTerm: Muscle weakness
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001733
      HPOTerm: Pancreatitis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002017
      HPOTerm: Nausea and vomiting
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002019
      HPOTerm: Constipation
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002315
      HPOTerm: Headache
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002574
      HPOTerm: Episodic abdominal pain
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002653
      HPOTerm: Bone pain
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0004398
      HPOTerm: Peptic ulcer
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0008696
      HPOTerm: Renal hamartoma
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0200025
      HPOTerm: Mandibular pain
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0002667
      HPOTerm: Nephroblastoma
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0002890
      HPOTerm: Thyroid carcinoma
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0006725
      HPOTerm: Pancreatic adenocarcinoma
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0010788
      HPOTerm: Testicular neoplasm
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0012032
      HPOTerm: Lipoma
  Prevalences:
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe 2011[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Lifetime Prevalence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Class only
      PrevalenceType: Annual incidence
      Source: 26708847[PMID]_17372919[PMID]_SEER Surveillance Epidemiology and End
        Results Program 2003[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Malta
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  TextSection:
    Contents: A rare endocrine tumor characterized by a malignant neoplasm derived
      from parathyroid parenchymal cells localized in one of the normally located
      parathyroid glands or other sites where parathyroid tissue may be present. Signs
      and symptoms are predominantly due to excess secretion of parathyroid hormone
      with marked hypercalcemia and renal and bone involvement. In rare cases the
      tumor may be non-functioning and only present as a palpable mass in the neck
      region. Recurrent laryngeal nerve paralysis is also observed. The tumor can
      occur sporadically or on a genetic background. The extent of invasion of adjacent
      structures positively correlates with the development of recurrent or metastatic
      disease.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2022
  creationDate: '2022-06-14 15:58:09'
  version: 1.3.16 / 4.1.7 [2022-01-26] (orientdb version)
